Skip to main content

CVE:CRM - (CRM.V) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New (CRM.V) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$0.00
This price target is based on 0 analysts offering 12 month price targets for (CRM.V) in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in (CRM.V). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/15/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/17/2017CIBCDowngradeSector Outperform ➝ Sector Perform
i
(Data available from 5/8/2016 forward)
(CRM.V) logo
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,671,836 shs

Average Volume

5,832,858 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (CRM.V)?

The following Wall Street analysts have issued research reports on (CRM.V) in the last twelve months:
View the latest analyst ratings for CRM.

What is the current price target for (CRM.V)?

0 Wall Street analysts have set twelve-month price targets for (CRM.V) in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for (CRM.V) in the next year.
View the latest price targets for CRM.

What is the current consensus analyst rating for (CRM.V)?

(CRM.V) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CRM.

How do I contact (CRM.V)'s investor relations team?

(CRM.V)'s physical mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company's listed phone number is +1-604-6331440. The official website for (CRM.V) is investors.crhsystem.com.